— Know what they know.
Not Investment Advice
Also trades as: KTTAW (NASDAQ) · $vol 0M

KTTA NASDAQ

Pasithea Therapeutics Corp.
1W: -9.9% 1M: -2.0% 3M: +0.3% YTD: -41.0% 1Y: -26.5% 3Y: -90.2%
$0.70
-0.07 (-8.75%)
Pre-Market: $0.69 (-0.01, -1.95%)
Weekly Expected Move ±11.8%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 37 · $5.2M mcap · 7M float · 5.80% daily turnover · Short 39% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$5.2M
52W Range0.281-2.06
Volume318,556
Avg Volume424,811
Beta0.22
Dividend
Analyst Ratings
2 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOTiago Reis Marques
Employees4
SectorHealthcare
IndustryBiotechnology
IPO Date2021-09-15
1111 Lincoln Road
Miami Beach, FL 33139
US
702 514 4174
About Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Recent Insider Trades

NameTypeSharesPriceDate
Marques Tiago A-Award 1,756,069 $0.84 2026-05-01
STEINMAN LAWRENCE A-Award 152,783 $0.84 2026-05-01
Dumesnil Simon A-Award 152,783 $0.84 2026-05-01
Schneiderman Daniel A-Award 1,129,323 $0.84 2026-05-01
Krishnan Kartik A-Award 1,129,323 $0.84 2026-05-01

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms